HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease
出版年份 2019 全文链接
标题
HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease
作者
关键词
-
出版物
Journal of the American Heart Association
Volume 8, Issue 11, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-05-25
DOI
10.1161/jaha.118.011792
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis
- (2018) K. Paapstel et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusClinical Perspective
- (2016) Zahir H. Alshehry et al. CIRCULATION
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
- (2016) Reijo Laaksonen et al. EUROPEAN HEART JOURNAL
- Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice
- (2015) Aliki A. Rasmiena et al. ATHEROSCLEROSIS
- Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL
- (2015) Iryna Sutter et al. ATHEROSCLEROSIS
- HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages
- (2015) Brenda L. Sanchez-Gaytan et al. BIOCONJUGATE CHEMISTRY
- Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study
- (2014) Christin Stegemann et al. CIRCULATION
- Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease
- (2014) Peter J. Meikle et al. PHARMACOLOGY & THERAPEUTICS
- Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids
- (2013) Laurent Camont et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Group X Secreted Phospholipase A2 Limits the Development of Atherosclerosis in LDL Receptor–Null Mice
- (2013) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Quality Markers Addressing Preanalytical Variations of Blood and Plasma Processing Identified by Broad and Targeted Metabolite Profiling
- (2013) B. Kamlage et al. CLINICAL CHEMISTRY
- Plasma lipid profiling in a large population-based cohort
- (2013) Jacquelyn M. Weir et al. JOURNAL OF LIPID RESEARCH
- Third Universal Definition of Myocardial Infarction
- (2012) Kristian Thygesen et al. CIRCULATION
- Phospholipase A2 enzymes and the risk of atherosclerosis
- (2012) R. S. Rosenson et al. EUROPEAN HEART JOURNAL
- Plasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes
- (2012) Melissa N. Barber et al. PLoS One
- Plasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease
- (2011) Peter J. Meikle et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence
- (2008) Wolfgang Koenig et al. CARDIOVASCULAR DRUGS AND THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started